肝素结合性表皮生长因子类生长因子 (HB-EGF) 激活p38以影响肺纤维化
Yan An1,2, Su-Yan Yan3, Wei Xu1
1Department of Rheumatology and Immunology, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China.
Regenerative therapy
|May 27, 2024
概括
肝素结合性表皮生长因子类生长因子 (HB-EGF) 通过激活p38基因激活蛋白激酶 (MAPK) 途径来抑制肺纤维化. 这个过程影响下游炎症因子的表达,提供了潜在的治疗点.
科学领域:
- 肺部医学 肺部医学
- 细胞生物学 细胞生物学
- 免疫学 免疫学 免疫学
背景情况:
- 肺纤维化是一种衰弱的肺部疾病,治疗选择有限.
- 肝素结合性表皮生长因子类生长因子 (HB-EGF) 与各种细胞过程有关,但其在肺纤维化中的作用需要澄清.
- 线粒激活蛋白激酶 (MAPK) 信号通路,特别是p38,是炎症和纤维化的一个关键调节器.
研究的目的:
- 为了研究HB-EGF对肺纤维化的作用.
- 为了确定HB-EGF是否在肺纤维化背景下激活p38 MAPK通路.
- 检查HB-EGF对下游炎症因子表达的影响.
主要方法:
- 量化PCR (qPCR),西式涂抹和ELISA用于测量患者样本中的HB-EGF, I型原蛋白 (COL-I) 和六酶2 (HK2).
- 在体外实验中使用了人类胚胎肺纤维细胞细胞系 (A549和MRC-5).
- 用HB-EGF和转化生长因子-β1 (TGF-β1) 治疗细胞,以评估基因和蛋白质表达变化,包括p38激活和炎症标志物.
主要成果:
- 结合组织疾病相关的间歇性肺病 (CTD-ILD) 患者的HB-EGF水平升高.
- 在肺纤维细胞中,HB-EGF刺激增加了I型原蛋白 (COL-I) 和α-平滑肌肉动蛋白 (α-SMA) 的表达.
- HB-EGF以度依赖的方式激活了p38 MAPK通路,导致IL-6和TNF-α等炎症因子的表达变化.
结论:
- 在促进肺纤维化方面,HB-EGF发挥着重要作用.
- p38 MAPK通路是HB-EGF亲纤维效应的关键调解者.
- 针对HB-EGF/p38 MAPK轴可能为肺纤维化提供一种新的治疗策略.
相关概念视频
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
TGF - β Signaling Pathway
7.3K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.3K
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
155
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
155
Regulation of Angiogenesis and Blood Supply
2.6K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.6K
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
2.2K
Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.2K
MAPK Signaling Cascades
5.4K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.4K


